- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on NMO Spectrum Disorder (NMOSD) in Norway
Total 78 results
-
Eli Lilly and CompanyCompletedSchizophrenia | Bipolar DisorderRussian Federation, United States, Puerto Rico
-
Otsuka Pharmaceutical Development & Commercialization...Completed
-
Janssen Scientific Affairs, LLCCompletedSchizophrenia | Bipolar DisorderUnited States
-
Eli Lilly and CompanyCompletedDepression | Schizophrenia | Schizoaffective DisorderUnited States
-
SunovionCompletedSchizophrenia | Schizoaffective DisorderUnited States, Israel, Chile, South Africa, Argentina, Brazil, Croatia, Thailand
-
Janssen Pharmaceutica N.V., BelgiumCompletedSchizophreniaUnited Kingdom, Slovenia, Denmark, Finland, France, Greece, Israel, Norway, Sweden, Switzerland
-
AstraZenecaCompletedSchizophreniaBulgaria, Czech Republic, South Africa, United Kingdom, Germany, Hungary, Romania, Slovakia, Norway
-
AbbVieTerminatedSchizophreniaUnited States, Russian Federation, United Kingdom
-
UMC UtrechtCompletedSchizophreniaNetherlands, Norway, Austria, Belgium, Bulgaria, Czechia, Denmark, Germany, Greece, Hungary, Israel, Italy, Poland, Romania, Spain, United Kingdom
-
Indivior Inc.CompletedSchizophreniaUnited States
-
AmgenTerminatedSchizophreniaUnited States, Canada, Spain, Australia, New Zealand, Russian Federation, Singapore
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedSchizophreniaUnited States, Bulgaria
-
Otsuka Pharmaceutical Development & Commercialization...CovanceCompletedSchizophreniaSpain, Korea, Republic of, United States, Russian Federation, Chile, Estonia, Finland, Mexico, Hungary, Bulgaria, Croatia, Serbia, France, Poland, Romania, Thailand, Puerto Rico, Slovakia, Taiwan, Australia, India, Argentina, South... and more
-
Boehringer IngelheimActive, not recruitingClinical Trial of Iclepertin Effect on Cognition and Functional Capacity in Schizophrenia (CONNEX-1)SchizophreniaSweden, Canada, Italy, Japan, United States, Turkey, Greece, Germany, China, New Zealand, Australia, Mexico, Philippines, Poland, Brazil, Colombia, Norway
-
Hoffmann-La RocheCompletedSchizophreniaGermany, Spain, Turkey, Canada, United States, Netherlands, Chile, Brazil, Taiwan, Poland, Ukraine, Slovakia, Lithuania, Latvia
-
Hoffmann-La RocheCompletedSchizophreniaGermany, Spain, Turkey, Canada, United States, Netherlands, Chile, Brazil, Taiwan, Poland, Ukraine, Slovakia, Lithuania, Latvia
-
ACADIA Pharmaceuticals Inc.CompletedSchizophreniaUnited States, Spain, Hungary, Bulgaria, Russian Federation, Serbia, Ukraine, Poland, Canada, Czechia
-
AbbVie (prior sponsor, Abbott)CompletedCognitive Deficits in SchizophreniaUnited States
-
Otsuka Pharmaceutical Development & Commercialization...Completed
-
Otsuka Pharmaceutical Development & Commercialization...CompletedSchizophreniaUnited States, Argentina, Bulgaria, India, Malaysia, Mexico, Philippines, Romania, Russian Federation, Serbia, Slovakia, Taiwan
-
Otsuka Pharmaceutical Development & Commercialization...CompletedSchizophreniaUnited States, India, South Africa, Estonia, Russian Federation, Mexico, Korea, Republic of, Malaysia, Bulgaria, Hungary, Croatia, Serbia, Poland, Romania, Puerto Rico, Slovakia, Chile, Taiwan, Thailand, Australia, Spain, Argentina, Finlan... and more
-
Boehringer IngelheimRecruitingSchizophreniaKorea, Republic of, Canada, United States, Taiwan, United Kingdom, Chile, Serbia, Brazil, China, Colombia, Germany, Greece, Italy, Japan, Mexico, Norway, Poland, Sweden, Spain, Argentina, Croatia, France, Slovakia, Denmark, Australia, Mal... and more
-
AbbVie (prior sponsor, Abbott)CompletedSchizophreniaUnited States, Russian Federation, United Kingdom
-
New York State Psychiatric InstituteColumbia University; National Institute on Aging (NIA)CompletedAggression | Psychotic Disorders | Alzheimer Disease | AgitationUnited States
-
FORUM Pharmaceuticals IncSyneos Health; NeuroCog Trials, Inc.CompletedSchizophrenia | Impaired CognitionUnited States, Ukraine, United Kingdom, Poland, Romania, Russian Federation, Italy, Mexico, Colombia, Argentina, Australia, Brazil
-
FORUM Pharmaceuticals IncSyneos HealthCompletedSchizophrenia | Impaired CognitionUnited States, Ukraine, United Kingdom, Germany, Spain, Argentina, Canada, Singapore, Russian Federation, Italy, Mexico, Colombia, Australia, Belgium, Poland, Romania
-
Solvay PharmaceuticalsTerminatedPsychosis and Behavioral Disturbances Associated With Dementia of the Alzheimer's TypeUnited States, Czech Republic, Estonia, Israel, Poland